Yet how will our system contemplate funding high-cost therapies that deliver potentially curative benefits over such a wide range of years - from 5 to 75 years. …
New CAR-T data once again highlights the evaluation challenge
June 5, 2019 Latest NewsNews of the Day
Latest Video
New Stories
-
Gilead announces first grants under new HIV program
January 29, 2020 - - Latest News -
MA: Would be 'surprised' by any approach for savings
January 29, 2020 - - Latest News -
Greg Hunt to host the first meeting of NMP review stakeholder group
January 29, 2020 - - Latest News -
MSAC: Advises government to 'utilise' competition on CAR-T
January 29, 2020 - - Latest News -
When was the last time a health minister did that?
January 28, 2020 - - Latest News -
Recognition for Department of Health official
January 28, 2020 - - Latest News -
More confirmed speakers for BioPharmaDispatch 2020
January 28, 2020 - - Latest News